why choose us

First received: September 13, 2023

Clinical Trial: A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Generalized Anxiety Disorder

Study Type: INTERVENTIONAL


Official Title: A Phase 2a, Randomized, Double-Blind, Active-Controlled Study to Assess the Preliminary Clinical Efficacy, Safety, Tolerability, and Pharmacokinetics, of CYB004 in Participants With Generalized Anxiet

Brief Summary: The purpose of this proof-of-concept trial is to examine the safety, tolerability, and pharmacokinetics (PK), and preliminary clinical efficacy of CYB004 participants with GAD.

Read more